Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: Results of a phase II study
Authors:
- Marc A BolletMBMarc A Bollet
- Institut Curie Breast Cancer Study GroupIGInstitut Curie Breast Cancer Study Group
- 1 September 2006
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (14) , 2286-2295
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2005
- Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survivalAnnals of Oncology, 2005
- Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18Journal of the National Cancer Institute Monographs, 2001
- Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902Journal of Clinical Oncology, 2001
- Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-AnalysisJournal of Clinical Oncology, 2000
- Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trialBreast Cancer Research and Treatment, 1999
- Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-upAnnals of Oncology, 1999
- Medullary breast carcinoma: The role of radiotherapy as primary treatmentRadiotherapy and Oncology, 1987
- Radiation therapy as primary treatment for early stage carcinoma of the breastCancer, 1975